France· FR:61854766
RIZATRIPTAN ARROW 10 mg, comprimé
A rizatriptan product containing benzoate de rizatriptan, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Rizatriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC04 (rizatriptan), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Rizatriptan · ATC N02CC04
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of rizatriptan costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.25 in France to $10.95 in Switzerland — a ×8.8 gap.
- France: $1.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Rizatriptan · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$10.95
- ES Spain$5.01
- IT Italy$2.91
- FR France$1.25
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BENZOATE DE RIZATRIPTAN
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- N02CC04
- ATC class
- Rizatriptan
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400926708689plaquette(s) polyamide aluminium PVC-Aluminium de 12 comprimé(s)EUR 13.11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for rizatriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rizatriptan · interactions on record
106 records
- 11 severe
- 6 moderate
- 88 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rizatriptan in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMaxalt 10mg tabletsWaymade Healthcare Plc
- SpainMAXALT 10 mg COMPRIMIDOSOrganon Salud S.L.
- CanadaACT RIZATRIPTANTEVA CANADA LIMITED
- SwedenRizatriptan Ebb 10 mg TablettEbb Medical AB
- SwitzerlandMaxalt 10 mg, TablettenOrganon GmbH
- ItalyMAXALTORGANON ITALIA S.R.L.
- NetherlandsMaxalt 10 mg, tablettenN.V. Organon
- IcelandMaxalt SmeltN.V. Organon*
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Rizatriptan Al, Rizatriptan Glenmark
- Denmark · Rizasmelt, Rizatriptan ”stada”
- Spain · Rizatriptán Flas Kern Pharma, Rizatriptán Max Viatris
- Finland · Rizastad, Rizatriptan Stada
- United Kingdom (Northern Ireland) · Rizatriptan Glenmark Pharmaceuticals Europe, Rizatriptan Macleods Pharma Uk
- Croatia · Emalt
- Italy · Rizatriptan Mylan Generics, Rizatriptan Sandoz
- Netherlands · Rizatriptan Sandoz, Rizatriptan Viatris
- Sweden · Rizasmelt, Rizatriptan Glenmark
- Slovakia · Rizatriptan Sandoz, Rizatriptan Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9402a67-f63e-448d-a13b-c5c14f73a079 GET /v1/drugs/d9402a67-f63e-448d-a13b-c5c14f73a079?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61854766",
"date_amm": "2013-04-22",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "BENZOATE DE RIZATRIPTAN",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rizatriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.